Evidence map›Paper›PMID 30443031›Full record

ReviewNature reviews. Cardiology2019

Abdominal aortic aneurysm: update on pathogenesis and medical treatments.

Jonathan Golledge

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 423 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
423citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05361772 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial

TypeinterventionalSponsorGuangdong Provincial People's HospitalRan2022 to 2025Enrolled230ConditionsColchicine, Abdominal Aortic Aneurysm, ProgressionArmscolchicine, Placebo
NCT06775821 recruitingnot on this mapstarted 2022, after this paper: background citation

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Typeobservational_patient_registrySponsorFirst Affiliated Hospital of Kunming Medical UniversityRan2022 to 2025Enrolled2,000ConditionsAbdominal Aortic Aneurysm, Primary Lung Cancer, PrevalenceArmsUltrasound or CT of the abdominal aorta
3 · Its place in the literature

Who cites it

423 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hemodynamic Metrics and Arterial Dysfunction: Insights From a Novel Microfluidic Device.International journal for numerical methods in biomedical engineering · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

363 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jonathan GolledgeQueensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia. jonathan.golledge@jcu.edu.au.

Funding

Medical Research Council
6 · The paper itself

Abstract

Abdominal aortic aneurysm (AAA) rupture is an important cause of death in adults. Currently, the only treatment for AAA is open or endovascular surgical repair. In most parts of the developed world, AAAs can be identified at an early stage as a result of incidental imaging and screening programmes. Randomized clinical trials have demonstrated that early elective surgical repair of these small AAAs is not beneficial, and an unmet clinical need exists to develop medical therapies for small AAAs that limit or prevent the progressive expansion and rupture of the aneurysm. A large amount of research is currently being performed to increase the understanding of AAA pathogenesis and ultimately lead to the development of medical therapies, such as drug-based and cell-based strategies for this disease. This Review summarizes the latest research findings and current theories on AAA pathogenesis, including discussion of the pros and cons of current rodent models of AAA, and highlights potential medical therapies for AAA, summarizing previous, ongoing and potential clinical trials of medical interventions for small AAAs. This expanding volume of research on AAA is expected to result in a range of novel medical therapies for AAA within the next decade.

Indexed as

Stem Cell TransplantationAnimalsAortic Aneurysm, AbdominalAortic RuptureCardiovascular AgentsDisease Models, AnimalHumansMolecular Targeted TherapyRisk FactorsTreatment OutcomeCardiovascular Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.